Melissa Lama
Adult Health · Ponchatoula, LANPI 1134489032
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 762 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 55 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 762 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- AbbVie$1K
- Lilly USA, LLC$832
- Pfizer$801
- Amgen$705
- plus $5K from 49 others
What the payments were for
- Food & beverage$13,32399%
- Education$851%
- Gifts$590%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,468 in reported general payments places this provider in the 95th percentile of 203 adult health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 179 | $157,999 |
| OzempicSemaglutide | 124 | $144,669 |
| MounjaroTirzepatide | 109 | $138,536 |
| JardianceEmpagliflozin | 89 | $77,743 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 96 | $72,088 |
| EliquisApixaban | 69 | $64,564 |
| VascepaIcosapent Ethyl | 106 | $44,994 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 56 | $42,009 |
| VraylarCariprazine Hcl | 30 | $41,058 |
| JanuviaSitagliptin Phosphate | 41 | $33,343 |
| TrulicityDulaglutide | 23 | $33,270 |
| ProliaDenosumab | 18 | $30,724 |
| EntrestoSacubitril/Valsartan | 30 | $29,856 |
| RybelsusSemaglutide | 17 | $26,954 |
| MyrbetriqMirabegron | 55 | $26,895 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $2,434 | $214,287290 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $421 | $175,275156 claims |
| Lilly USA, LLCMounjaro, Trulicity | $832 | $171,806132 claims |
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat, Jentadueto | $482 | $106,143137 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $2,022 | $96,566135 claims |
| PfizerEliquis | $801 | $64,56469 claims |
| AbbVieVraylar, Linzess | $1,405 | $55,18649 claims |
| MerckJanuvia, Belsomra, Janumet Xr | $162 | $46,04975 claims |
| AmgenProlia | $705 | $30,72418 claims |
| NovartisEntresto | $107 | $29,85630 claims |
| Astellas Pharma US IncMyrbetriq | $348 | $26,89555 claims |
| Johnson & JohnsonXarelto | $127 | $14,80420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 203 adult health providers in Louisiana.
Other adult health in Ponchatoula
- Joan SmithBaton Rouge$121K
- Fiona WinterbottomNew Orleans$51K
- Damika HarmonLake Charles$27K
- Jade CarrereHouma$23K
- Deborah SmithBaton Rouge$18K
- Tanisha SmithBaton Rouge$17K
- Eva Marina StaffordBaton Rouge$15K
- Dustin DenicolaBaton Rouge$14K
- Wendy GillBaton Rouge$13K
- Jennifer LeblancBaton Rouge$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.